Primary hyperhidrosis (PH) still impacts negatively the patient’s quality of life (QoL). Progressively, it leads to poorer QoL regardless of gender. The endoscopic thoracic sympathectomy has been used safely and effectively for control of palmar hyperhidrosis, but it is still questionable in palmo-plantar type. We assessed the benefits of uniportal drainless thoracoscopic sympathectomy (UDTS) for palmo-plantar hyperhidrosis patients compared to palmar ones. This prospective study comprised 213 consecutive patients with PH. They underwent bilateral simultaneous UDTS. We used the Hyperhidrosis Disease Severity Scale (HDSS) scoring system for assessment of QoL pre- and postoperatively. Follow-up was continued for 1-year that was aiming to detect the QoL improvement, recurrence, and compensatory hyperhidrosis (CH). All patients experienced immediate complete resolution of hyperhidrosis postoperatively. Recurrence was encountered in one patient during the first 6 months. All patients had improved QoL postoperatively, but at the end of 1-year follow-up, 2.8% of patients were still suffering moderate to severe impaired QoL. Mean hospital stay was 31.79 ± 17.5 h. We found significant longer hospital stay in palmar group than palmo-plantar group. There was no significant difference between both groups in neither operative time, recurrence, nor CH. UDTS offers better QoL for patients with PH even the palmo-plantar type. The palmo-plantar type benefits similarly to the palmar type in terms of comparable postoperative QoL and CH incidence.

中文翻译：

---

单门电视辅助胸腔镜无引流交感神经切除术治疗手掌和掌-多汗症：机构经验

原发性多汗症（PH）仍会对患者的生活质量（QoL）产生负面影响。无论性别如何，它都会导致生活质量较差。内窥镜胸交感神经切除术已被安全有效地用于控制手掌多汗症，但在掌-型中仍存在疑问。我们评估了单掌无创胸腔镜交感神经切除术（UDTS）对掌-多汗症患者的疗效。这项前瞻性研究包括213位连续的PH患者。他们同时接受了双边UDTS。我们使用多汗症疾病严重程度评分（HDSS）评分系统对术前和术后QoL进行评估。随访持续了1年，旨在检测QoL的改善，复发和代偿性多汗症（CH）。所有患者术后多汗立即消失。在最初的6个月中，一名患者复发。所有患者术后QoL均得到改善，但在1年随访期结束时，仍有2.8％的患者仍患有中度至重度QoL受损。平均住院时间为31.79±17.5小时。我们发现手掌组的住院时间明显长于脚掌-足底组。两组患者的手术时间，复发率和CH均无统计学差异。UDTS即使是掌-型也可为PH患者提供更好的QoL。就可比的术后QoL和CH发生率而言，掌-型的益处与掌type型相似。所有患者术后QoL均得到改善，但在1年随访结束时，仍有2.8％的患者仍患有中度至重度QoL受损。平均住院时间为31.79±17.5小时。我们发现手掌组的住院时间明显长于脚掌-足底组。两组患者的手术时间，复发率和CH均无统计学差异。UDTS即使是掌-型也可为PH患者提供更好的QoL。就可比的术后QoL和CH发生率而言，掌-型的益处与掌type型相似。所有患者术后QoL均得到改善，但在1年随访结束时，仍有2.8％的患者仍患有中度至重度QoL受损。平均住院时间为31.79±17.5小时。我们发现手掌组的住院时间明显长于脚掌-足底组。两组患者的手术时间，复发率和CH均无统计学差异。UDTS即使是掌-型也可为PH患者提供更好的QoL。就可比的术后QoL和CH发生率而言，掌-型的益处与掌type型相似。两组患者的手术时间，复发率和CH均无统计学差异。UDTS即使是掌-型也可为PH患者提供更好的QoL。就可比的术后QoL和CH发生率而言，掌-型的益处与掌type型相似。两组患者的手术时间，复发率和CH均无统计学差异。UDTS即使是掌-型也可为PH患者提供更好的QoL。就可比的术后QoL和CH发生率而言，掌-型的益处与掌type型相似。